© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
AMCP Annual
AMCP 2022 Wrap-Up
April 05, 2022
About 3,000 people attended the Academy of Managed Care Pharmacy's annual meeting in Chicago last week.
AMCP 2022: Digital Therapeutics and the Medical, Pharmacy Benefit: Which Side Should They Go On?
April 01, 2022
Pear Therapeutics’ Yuri Maricich says the company hasn’t “put a stake in the ground” on the question but says standardizations is important.
AMCP 2022: Walgreens Used Targeted Outreach to Boost COVID-19 Vaccination in Socially Vulnerable Areas
April 01, 2022
A COVID-19 risk score helped steer outreach efforts to people who weren’t getting vaccinated by the pharmacy chain earlier in the pandemic.
AMCP 2022: Research Looks at Medication Use in Rare Liver Disease
April 01, 2022
Insurers need a better understanding of patients’ adherence and discontinuation of medication for primary biliary cholangitis, according to AllianceRx Walgreens Prime study.
AMCP 2022: Zahra Mahmoudjafari of University of Kansas Health System Discusses CAR T-Cell Therapies in Managed Care
April 01, 2022
Zahra Mahmoudjafari, PharmD, BCOP, clinical pharmacy manager of Hematology/BMT/Cellular Therapeutics at University of Kansas Health System discussed CAR T-Cell therapies in managed care at the annual AMCP 2022 conference in Chicago.
AMCP 2022: RWE Research Keeps Coming on Strong, Say JMCP Editor-in-Chief
April 01, 2022
Real-world studies are increasing as real-world data for new drugs for cancer and autoimmune disease have “matured,” says Laura E. Happe, Pharm.D., M.P.H., the editor-in-chief of Journal of Managed Care and Specialty Pharmacy.
AMCP 2022: Katie Lockhart of Magellan Health Talks the Financial Impact of Specialty Drugs & Cost-Impact Models
March 31, 2022
Katie Lockhart, MA, manager of Magellan Health, addresses her AMCP 2022 conference session on the financial impact of specialty drugs and cost-impact models.
AMCP 2022: Soumya Vishwanath of Magellan Rx Management Addresses Digital Therapeutics at AMCP 2022
March 31, 2022
Soumya Vishwanath, PharmD, senior manager of Formulary Strategy at Magellan Rx Management, talked about digital therapeutics in the behavioral health space and formulary strategy space during the annual AMCP 2022 conference in Chicago.
AMCP 2022: High Out-of-Pocket Costs Are Associated with Nonadherence Among Patients Taking Oral Cancer Drugs
March 31, 2022
“Popping a pill” makes cancer treatment more convenient, but research presented at the AMCP annual meetings shows that almost half of cancer patients on oral therapies are nonadherent. Oral administration typically moves a drug to the pharmacy benefit, which can mean high out-of-pocket costs and, in turn, nonadherence.
AMCP 2022: Prevalence of Alopecia Areata Is Increasing
March 31, 2022
Using a claims database, researchers found a steady increase in the prevalence of alopecia areata from 2016 to 2019 among those with employer-based health insurance. They also found a higher prevalence and incidence rate among women than among men.